Nasser H Hanna MD
Associate Professor, Medicine, Indiana University School of Medicine
Join to View Full Profile
535 Barnhill Dr# ROUTE473Indianapolis, IN 46202
Phone+1 317-278-0054
Dr. Hanna is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1998 - 2000
University of Iowa Health Care Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Missouri-Columbia School of MedicineClass of 1995
Certifications & Licensure
IN State Medical License 1999 - 2027
IA State Medical License 1995 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2016
- CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2016
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2016
Clinical Trials
- Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Start of enrollment: 2006 Feb 23
- Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer Start of enrollment: 2002 Feb 01
- Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Start of enrollment: 2005 May 01
Publications & Presentations
PubMed
- Tobacco Use, Knowledge of Harms, and Treatment Support Among Patients With Non-Tobacco-Related Cancers: A Multi-Center Survey Study.Raul Gregg-Garcia, Vidya Dandu, Laura B Vater, Karen Suchanek Hudmon, Deborah Buckles
Cancer Medicine. 2026-05-01 - Measurement of patients' acceptable symptom levels and priorities for symptom improvement in advanced prostate cancer.Stella Snyder, Ekin Secinti, Ellen F Krueger, Nabil Adra, Roberto Pili
Supportive Care in Cancer. 2026-01-03 - Comprehensive Genomic Profiling of Rare Lung Tumors: Adenosquamous Carcinoma and Pulmonary Carcinosarcoma.Tianhao Zhou, Olivia C Terry, Katherine G Minton, Lisa Poole, Stephen V Liu
Journal of Thoracic Oncology. 2025-11-01
Other
- Adjuvant systemic therapy in resectable non-small cell lung cancerHanna N
http://www.uptodate.com/contents/adjuvant-systemic-therapy-in-resectable-non-small-cell-lung-cancer
UpToDate, Wolters Kluwer Health - 2013-03-25
Press Mentions
2025 President’s Address: “Driving Knowledge to Action: Building a Better Future”June 1st, 2025- Doctors Urge More Smokers to Get Annual Lung Cancer ScreeningsMarch 8th, 2025
- Honoring a Father’s Life and LegacyNovember 17th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
